Lazard Capital expects Vera Bradley's Q2 results to miss guidance and consensus estimates and reiterates a Sell rating on the stock with a $16 price target. The firm also thinks the company's Q3 outlook to miss estimates due to sales below plan and promotions above plan.
- Stocks & Offerings
- Investment & Company Information
- Vera Bradley